ASHP guidelines on home infusion pharmacy services

American Journal of Health-System Pharmacy

Volumn 71, Issue 4, 2014, Pages 325-341

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED SUBSTANCE;

ARTICLE; CAREGIVER; CLINICAL ASSESSMENT; CONSULTATION; DATA BASE; DOCUMENTATION; DRUG INFORMATION; EMERGENCY CARE; ENTERIC FEEDING; FINANCIAL MANAGEMENT; FOLLOW UP; HAZARDOUS WASTE; HEALTH CARE PERSONNEL; HOME CARE; HOSPITAL DEPARTMENT; HUMAN; INFORMATION SERVICE; INFORMATION TECHNOLOGY; INFUSION; INSURANCE; INTERPERSONAL COMMUNICATION; LAW; LICENSING; MEDICAL RECORD; MEDICATION ERROR; MEDICATION THERAPY MANAGEMENT; NURSE; ORIENTATION; PARENTERAL NUTRITION; PATIENT CARE; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT SAFETY; PATIENT SATISFACTION; PHARMACIST; PHARMACY; POST EXPOSURE PROPHYLAXIS; PRACTICE GUIDELINE; QUALITY CONTROL; REIMBURSEMENT; SUBSTANCE ABUSE; TRAINING; WASTE MANAGEMENT; WORK SCHEDULE; HEALTH CARE ORGANIZATION; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PROFESSIONAL STANDARD; STANDARD; UNITED STATES;

HOME INFUSION THERAPY; HUMANS; PHARMACEUTICAL SERVICES; PHARMACISTS; PRACTICE GUIDELINES AS TOPIC; PROFESSIONAL ROLE; SOCIETIES, PHARMACEUTICAL; UNITED STATES;

EID: 84903180679     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/sp140004     Document Type: Article

References (27)

1. Health Insurance Portability and Accountability Act of 1996. Pub. L. No. 104-191. www.cms.hhs.gov/HIPAAGenInfo/Downloads/HIPAALaw.pdf (accessed 12 February 2011).
2. U.S. Department of Health and Human Services Office of Inspector General Exclusions Program. http://oig.hhs.gov/fraud/exclusions.asp (accessed 12 January 2011).
3. American Society of Hospital Pharmacists. ASHP statement on continuing education. Am J Hosp Pharm. 1990; 47:1855.
4. United States Department of Labor Occupational Safety & Health Administration. http://osha.gov/SLTC/bloodbornepathogens/index.html (accessed 12 February 2011).
5. National Institute of Occupational Safety and Health. NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2010. www.cdc.gov/niosh/docs/2010-167/pdfs/2010-167.pdf (accessed 12 February 2011).
6. United States Department of Labor Occupations Safety & Health Administration, Hazard Communication: Foundation of Workplace Chemical Safety Program. www.osha.gov/dsg/hazcom/index.html (accessed 12 February 2011).
7. American Society of Health-System Pharmacists. ASHP guidelines on quality assurance for pharmacy-prepared sterile products. Am J Health-Syst Pharm. 2000; 57:1150-69.
8. Pharmaceutical compounding - sterile preparations (general information chapter 797). In: The United States pharmacopeia, 34th rev., and The national formulary, 29th ed. Rockville, MD: The United States Pharmacopeial Convention; 2011: 336-73.
9. American Society of Health-System Pharmacists. ASHP guidelines on the pharmacy and therapeutics committee and the formulary system. Am J Health-Syst Pharm. 2008; 65:1272-83.
10. American Society of Health-System Pharmacists. ASHP guidelines on clinical drug research. Am J Health-Syst Pharm. 1998; 55:369-76.
11. American Society of Hospital Pharmacists. ASHP guidelines for pharmaceutical research in organized health-care settings. Am J Hosp Pharm. 1989; 46:129-30.
12. American Society of Health-System Pharmacists. ASHP guidelines on the safe use of automated dispensing devices. Am J Health-Syst Pharm. 2010; 67:483-90.
13. American Society of Health-System Pharmacists. ASHP statement on the pharmacist's role in substance abuse prevention, education, and assistance. Am J Health-Syst Pharm. 2014; 71:243-6.
14. American Society of Health-System Pharmacists. ASHP guidelines on the pharmacist's role in the development, implementation, and assessment of critical pathways. Am J Health-Syst Pharm. 2004; 61:939-45.
15. American Society of Hospital Pharmacists. ASHP guidelines for selecting pharmaceutical manufacturers and suppliers. Am J Hosp Pharm. 1991; 48:523-4.
16. American Society of Health-System Pharmacists. ASHP guidelines on medication cost management strategies for hospitals and health systems. Am J Health-Syst Pharm. 2008; 65:1368-84.
17. American Society of Health-System Pharmacists (ASHP). ASHP Drug Shortages Resource Center. www.ashp.org/shortages (accessed 21 Mar 2013).
18. U.S. Food and Drug Administration. Drug shortages. www.fda.gov/cder/drug/shortages/ (accessed 21 Mar 2013).
19. American Society of Health-System Pharmacists. ASHP guidelines on managing drug product shortages in hospitals and health systems. Am J Health-Syst Pharm. 2009; 66:1399-406.
20. Institute for Safe Medication Practices (ISMP). ISMP's List of High-Alert Medications. www.ismp.org/tools/highalertmedications.pdf (accessed 21 Mar 2013).
21. American Society of Health-System Pharmacists. ASHP guidelines on outsourcing sterile compounding services. Am J Health-Syst Pharm. 2010; 67:757-65.
22. American Society of Health-System Pharmacists. ASHP guidelines on handling hazardous drugs. Am J Health-Syst Pharm. 2006; 63:1172-93.
23. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990; 47:533-43.
24. American Society of Health-System Pharmacists. ASHP guidelines on pharmacist-conducted patient education and counseling. Am J Health-Syst Pharm. 1997; 54:431-4.
25. American Society of Health-System Pharmacists. ASHP guidelines on adverse drug reaction monitoring and reporting. Am J Health-Syst Pharm. 1995; 52:417-9.
26. American Society of Health-System Pharmacists. ASHP statement on the role of health-system pharmacists in emergency preparedness. Am J Health-Syst Pharm. 2003; 60:1993-5.
27. American Society of Hospital Pharmacists. ASHP technical assistance bulletin on hospital drug distribution and control. Am J Hosp Pharm. 1980; 37:1097-103.